{
    "accessibility": "Open access",
    "additionDate": "2021-01-18T11:18:52Z",
    "bioagentsCURIE": "bioagents:dockcov2",
    "bioagentsID": "dockcov2",
    "collectionID": [
        "COVID-19"
    ],
    "confidence_flag": "agent",
    "credit": [
        {
            "email": "chienyuchen@ntu.edu.tw",
            "name": "Chien-Yu Chen",
            "typeEntity": "Person"
        },
        {
            "email": "yukijuan@ntu.edu.tw",
            "name": "Hsueh-Fen Juan",
            "typeEntity": "Person"
        }
    ],
    "description": "DockCoV2 is a drug database against SARS-CoV-2. It can be used for coronavirus (SARS-CoV-2) drug screening.",
    "editPermission": {
        "type": "private"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "Database search",
                    "uri": "http://edamontology.org/operation_2421"
                },
                {
                    "term": "Protein-protein docking",
                    "uri": "http://edamontology.org/operation_3899"
                },
                {
                    "term": "Virtual screening",
                    "uri": "http://edamontology.org/operation_3938"
                }
            ]
        }
    ],
    "homepage": "https://covirus.cc/drugs/",
    "lastUpdate": "2021-03-01T19:33:54Z",
    "license": "GPL-3.0",
    "link": [
        {
            "type": [
                "Repository"
            ],
            "url": "https://github.com/ailabstw/DockCoV2"
        }
    ],
    "name": "DockCoV2",
    "owner": "Kigaard",
    "publication": [
        {
            "doi": "10.1093/NAR/GKAA861",
            "metadata": {
                "abstract": "Â© 2021 The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.The current state of the COVID-19 pandemic is a global health crisis. To fight the novel coronavirus, one of the best-known ways is to block enzymes essential for virus replication. Currently, we know that the SARS-CoV-2 virus encodes about 29 proteins such as spike protein, 3C-like protease (3CLpro), RNA-dependent RNA polymerase (RdRp), Papain-like protease (PLpro), and nucleocapsid (N) protein. SARS-CoV-2 uses human angiotensin-converting enzyme 2 (ACE2) for viral entry and transmembrane serine protease family member II (TMPRSS2) for spike protein priming. Thus in order to speed up the discovery of potential drugs, we develop DockCoV2, a drug database for SARS-CoV-2. DockCoV2 focuses on predicting the binding affinity of FDA-approved and Taiwan National Health Insurance (NHI) drugs with the seven proteins mentioned above. This database contains a total of 3,109 drugs. DockCoV2 is easy to use and search against, is well cross-linked to external databases, and provides the state-of-the-art prediction results in one site. Users can download their drug-protein docking data of interest and examine additional drug-related information on DockCoV2. Furthermore, DockCoV2 provides experimental information to help users understand which drugs have already been reported to be effective against MERS or SARS-CoV. DockCoV2 is available at https://covirus.cc/drugs/.",
                "authors": [
                    {
                        "name": "Chang Y.-C."
                    },
                    {
                        "name": "Chen C.-Y."
                    },
                    {
                        "name": "Chen T.-F."
                    },
                    {
                        "name": "Hsiao Y."
                    },
                    {
                        "name": "Hsiao Y.-C."
                    },
                    {
                        "name": "Huang H.-C."
                    },
                    {
                        "name": "Juan H.-F."
                    },
                    {
                        "name": "Lee K.-H."
                    },
                    {
                        "name": "Lin Y.-H."
                    },
                    {
                        "name": "Tu Y.-C.E."
                    }
                ],
                "citationCount": 3,
                "date": "2021-01-08T00:00:00Z",
                "journal": "Nucleic Acids Research",
                "title": "DockCoV2: A drug database against SARS-CoV-2"
            },
            "pmid": "33035337"
        }
    ],
    "agentType": [
        "Database portal"
    ],
    "topic": [
        {
            "term": "Drug development",
            "uri": "http://edamontology.org/topic_3373"
        },
        {
            "term": "Drug discovery",
            "uri": "http://edamontology.org/topic_3336"
        },
        {
            "term": "Enzymes",
            "uri": "http://edamontology.org/topic_0821"
        },
        {
            "term": "Molecular modelling",
            "uri": "http://edamontology.org/topic_2275"
        },
        {
            "term": "Small molecules",
            "uri": "http://edamontology.org/topic_0154"
        }
    ]
}
